Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Phase III and other data on morphine/oxycodone combination reported

May 11, 2010

Proof-of-concept study in irritable bowel disease encourages larger studies with AST-120

May 11, 2010

Phase I safety data reported for orphan drug QPI-1002

May 11, 2010

Wnt signaling inhibitor CW-232291 to advance to phase I

May 11, 2010

CTS-1027 well tolerated in HCV patients failing prior treatments

May 11, 2010

Prostate cancer diagnostic 99mTc-EC-0652 to proceed to phase 0 clinical evaluation

May 11, 2010

Novel "two-in-one" antibody targeting EGFR/HER3 shows preclinical potential

May 11, 2010

Improvements seen with gene therapy in small study in severe retinal dystrophy

May 10, 2010

VX-222 development for hepatitis C advances

May 10, 2010

Long-lasting effects seen with NGX-4010 in postherpetic neuralgia patients

May 10, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...